Loading
Robert Hillman

Robert Hillman

CEO, CeleCor Therapeutics
United States
Robert S. Hillman, PhD, isa successful serial entrepreneur/inventor. He studied at Stanford University, MIT, and the Swiss Federal Institute of Technology (ETH-Z). Early in his career, Dr. Hillman led the development of the GenESA System, the first drug-device combination cleared by the FDA for diagnosing coronary artery disease. Dr. Hillman was also co-founder at Accumetrics, where he led the development of the VerifyNow System; Biotrack, where he lead the development of the CoaguCheck System; Tem Systems, where he led the development of the Rotem Sigma; and ActivX Biosciences, an early pioneer in activity-based proteomics. Many of these products are still in use today in hospitals and research institutions worldwide
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS